4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-001791
Director sold 7,056 shares at $86.45 ($609,991)
- Director acquired 7,056 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STONE HEISZ LESLIE · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-08 | Exercise or conversion : show line 1 in the form | +7,056 | $36.86 | $260,107 | 34,036 | D |
| 2024-02-08 | Sale : show line 2 in the form | −7,056 | $86.45 | $609,991 | 26,980 | D |
| Open-market sales · 7,056 sh · avg $86.45 · $609,991 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-02-08 | Exercise or conversion : show line 3 in the form Director Stock Option (Right to Acquire) | −7,056 | $36.86 | 2024-05-11 | 7,056 | 0 | D |
Loading xslF345X05/doc4.xml…